Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
FDMT - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative FDMT - 4D Molecular Therapeutics, Inc.
36.5 M
LAST VALUE
14.14%
2 YEAR CAGR
42.70%
5 YEAR CAGR
0.00%
10 YEAR CAGR